Cite
PO-0929: Dual-modality simultaneous orthogonal kV and portal MV imaging for verification of tumor tracking on SBRT patients.
MLA
Poels, K., et al. “PO-0929: Dual-Modality Simultaneous Orthogonal KV and Portal MV Imaging for Verification of Tumor Tracking on SBRT Patients.” Radiotherapy & Oncology, vol. 115, Apr. 2015, pp. S484–85. EBSCOhost, https://doi.org/10.1016/S0167-8140(15)40921-1.
APA
Poels, K., Verellen, D., Dhont, J., Engels, B., Collen, C., Burghelea, M., Gevaert, T., Depuydt, T., & De Ridder, M. (2015). PO-0929: Dual-modality simultaneous orthogonal kV and portal MV imaging for verification of tumor tracking on SBRT patients. Radiotherapy & Oncology, 115, S484–S485. https://doi.org/10.1016/S0167-8140(15)40921-1
Chicago
Poels, K., D. Verellen, J. Dhont, B. Engels, C. Collen, M. Burghelea, T. Gevaert, T. Depuydt, and M. De Ridder. 2015. “PO-0929: Dual-Modality Simultaneous Orthogonal KV and Portal MV Imaging for Verification of Tumor Tracking on SBRT Patients.” Radiotherapy & Oncology 115 (April): S484–85. doi:10.1016/S0167-8140(15)40921-1.